Skip to content

Expert Speakers at the 2nd RNA- Targeted Drug Discovery Summit Include: 

Speakers
RNA X - Undruggabe 1 (1)

At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the 2nd RNA- Targeted Drug Discovery Summit returns to reunite the leading minds from large pharma, innovative biotech and KOLs of academia to discuss unique discovery and development challenges that must be overcome for novel RNA targeted small molecule therapeutics to achieve their seemingly limitless potential.

For the 2nd year, network with the KOLs and RNA pioneers, to gain a comprehensive understanding on how to translate the first generation of RNA targeted small molecules into the clinic, stimulate the discussion of successfully targeting RNA via interfering with RNA-protein interactions and seize the therapeutic opportunity in hand by re-defining the undruggable nature of RNA.

What our expert speakers are looking forward to at this years event:

Potentially the best collection of speakers and thought leaders pursuing RNA with small molecules

Jennifer Petter
Founder & CSO
Arrakis Therapeutics

 

I am glad to be part of this symposium. It’s a great opportunity to learn and share experience with leaders in this fascinating, promising and growing area of drug discovery

Pramod Pandey
Principal Scientist
Merck Research Labs, Exploratory

Media Partners

genetherapynetbanner160x160 - jpg
SelectScience20Logo